Suppr超能文献

体外循环期间即时 ACT 凝血仪和抗 Xa 活性的评估。

Evaluation of Point-of-Care ACT Coagulometers and Anti-Xa Activity During Cardiopulmonary Bypass.

机构信息

Department of Anesthesia and Intensive Care, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Division of Clinical Haematology and Blood Transfusion, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

出版信息

J Cardiothorac Vasc Anesth. 2020 Nov;34(11):2921-2927. doi: 10.1053/j.jvca.2020.06.027. Epub 2020 Jun 12.

Abstract

OBJECTIVE

The activated clotting time (ACT) is used worldwide to confirm safe heparin anticoagulation for cardiopulmonary bypass. For the present study, the performances of 2 commonly used ACT devices were compared with each other and with anti-Xa levels throughout the surgical procedure in order to understand whether they can be used interchangeably.

DESIGN

Prospective study.

SETTING

Tertiary care center.

PARTICIPANTS

The study comprised 33 elective adult cardiac surgical patients.

INTERVENTIONS

Blood samples were taken at standard times throughout the surgery (after induction, after heparin bolus, 4 samples at 30-minute intervals during cardiopulmonary bypass, after protamine), and ACTs and anti-Xa levels were analyzed. Data were compared using receiver operating characteristics and LOESS regression.

MEASUREMENTS AND MAIN RESULTS

The correlation between anti-Xa levels and the Hemochron ACT (Instrumentation Laboratory, Bedford, MA) was acceptable (r = 0.82, 95% confidence interval [CI] 0.757-0.868; p < 0.0001), as was the correlation between anti-Xa levels and the i-STAT (Abbott Point of Care, Abbott Park, IL) (r = 0.81, 95% CI 0.738-0.858; p < 0.0001). The correlation between the 2 ACT methods was poorer (r = 0.77, 95% CI 0.707-0.828; p < 0.0001) than their correlation to anti-Xa levels. When compared with anti-Xa levels, the sensitivity and specificity were mediocre for both devices, although the i-STAT performed better than the Hemochron ACT. The Hemochron ACT read higher values than the i-STAT ACT throughout the course of the surgery.

CONCLUSION

The correlation between the Hemochron ACT and i-STAT ACT is moderate, and they have different sensitivity and specificity when compared with anti-Xa levels. This suggests that ACT devices should not be used interchangeably, but cut-off values for safe anticoagulation during cardiopulmonary bypass should be determined for each type of device, particularly when switching supplier.

摘要

目的

激活凝血时间(ACT)被广泛用于确认体外循环时肝素抗凝的安全性。本研究旨在比较两种常用的 ACT 设备的性能,并与整个手术过程中的抗 Xa 水平进行比较,以了解它们是否可以互换使用。

设计

前瞻性研究。

地点

三级医疗中心。

参与者

研究纳入 33 例择期成年心脏手术患者。

干预措施

在手术过程中的标准时间采集血样(诱导后、肝素推注后、体外循环期间每 30 分钟采集 4 个样本、鱼精蛋白后),并分析 ACT 和抗 Xa 水平。使用接收者操作特征和 LOESS 回归比较数据。

测量和主要结果

抗 Xa 水平与 Hemochron ACT(Instrumentation Laboratory,Bedford,MA)之间的相关性可接受(r=0.82,95%置信区间[CI]0.757-0.868;p<0.0001),抗 Xa 水平与 i-STAT(Abbott Point of Care,Abbott Park,IL)之间的相关性也可接受(r=0.81,95%CI0.738-0.858;p<0.0001)。两种 ACT 方法之间的相关性较差(r=0.77,95%CI0.707-0.828;p<0.0001),与抗 Xa 水平的相关性相比。与抗 Xa 水平相比,两种设备的敏感性和特异性均中等,尽管 i-STAT 的性能优于 Hemochron ACT。整个手术过程中,Hemochron ACT 的读数均高于 i-STAT ACT。

结论

Hemochron ACT 和 i-STAT ACT 之间的相关性适中,与抗 Xa 水平相比,它们的敏感性和特异性不同。这表明 ACT 设备不能互换使用,而应针对每种类型的设备确定体外循环期间安全抗凝的截止值,尤其是在更换供应商时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验